By Susan Gammon, Ph.D. -
A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47. E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease each year in the United States.
READ MORE ON SANFORD-BURNHAM MEDICAL RESEARCH
Breakthrough in cancer research - Scientists convert pancreatic cancer cells to normal using a protein
